ESC Premium Access

Fatal and non-fatal secondary events in 496173 individuals with a first episode of atrial fibrillation between 1987 and 2013- a Swedish register study

Presentation

About the speaker

Associate Professor Lena Bjorck

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)
0 follower

9 more presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)

Thumbnail

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Bromma, SE)

Thumbnail

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)

Thumbnail

Access the full session

Anticoagulation in atrial fibrillation

Speakers: Associate Professor L. Bjorck, Assistant Professor B. Hornestam, Associate Professor L. Friberg, Doctor P. Noseworthy, Doctor P. Noseworthy...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk